Literature DB >> 31922712

Subgenomic RNA from Dengue Virus Type 2 Suppresses Replication of Dengue Virus Genomes and Interacts with Virus-Encoded NS3 and NS5 Proteins.

Sai Wang1, Kitti W K Chan1, Kishore B Naripogu1, Crystall M D Swarbrick1,2, John Aaskov3, Subhash G Vasudevan1,2.   

Abstract

Viral defective interfering particles (DIPs) with more than 90% of the genomic RNA (gRNA, ∼11 000 nucleotides) deleted have been detected in sera from dengue patients. The DIP RNA contains stem-loop structures in the 5' and 3' end, which may permit RNA replication in the same manner as dengue virus (DENV) gRNA. Transfection of DENV2 infected human hepatoma cells with DIP RNA (DIP-296) resulted in significant inhibition of virus replication. DIP-296 RNA inhibited DENV replication in a dose-dependent manner in several cell lines tested. The mechanism of inhibition by DIP RNA is unclear; however, our studies imply that the retinoic acid-inducible gene 1 (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) mediated innate immune antiviral signaling pathways and direct interactions of DIP RNA with viral replication proteins may be involved. The latter is supported by in vitro RNA electrophoretic mobility shift assays (REMSAs), which show that DIP RNA can bind directly to the DENV nonstructural proteins NS3 and NS5.

Entities:  

Keywords:  defective interfering particle; dengue virus; genome replication; innate immunity; nonstructural protein NS3; nonstructural protein NS5

Mesh:

Substances:

Year:  2020        PMID: 31922712     DOI: 10.1021/acsinfecdis.9b00384

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  8 in total

1.  Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase.

Authors:  Rolando Cannalire; Kitti Wing Ki Chan; Maria Sole Burali; Chin Piaw Gwee; Sai Wang; Andrea Astolfi; Serena Massari; Stefano Sabatini; Oriana Tabarrini; Eloise Mastrangelo; Maria Letizia Barreca; Violetta Cecchetti; Subhash G Vasudevan; Giuseppe Manfroni
Journal:  ACS Med Chem Lett       Date:  2020-03-19       Impact factor: 4.345

2.  Comparison of the performance of magnetic targeting drug carriers prepared using two synthesis methods.

Authors:  Zhen Shi; Yazhen Wang; Shaobo Dong; Tianyu Lan
Journal:  RSC Adv       Date:  2021-06-09       Impact factor: 4.036

3.  Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity.

Authors:  Dongsheng Li; Min-Hsuan Lin; Daniel J Rawle; Hongping Jin; Zhonglan Wu; Lu Wang; Mary Lor; Mazhar Hussain; John Aaskov; David Harrich
Journal:  Commun Biol       Date:  2021-05-11

4.  Structures of flavivirus RNA promoters suggest two binding modes with NS5 polymerase.

Authors:  Eunhye Lee; Paul J Bujalowski; Tadahisa Teramoto; Keerthi Gottipati; Seth D Scott; Radhakrishnan Padmanabhan; Kyung H Choi
Journal:  Nat Commun       Date:  2021-05-05       Impact factor: 17.694

5.  Preparation and Thermal Decomposition Kinetics of a New Type of a Magnetic Targeting Drug Carrier.

Authors:  Zhen Shi; Yazhen Wang; Tianyuan Xiao; Shaobo Dong; Tianyu Lan
Journal:  ACS Omega       Date:  2021-01-22

6.  A conserved arginine in NS5 binds genomic 3' stem-loop RNA for primer-independent initiation of flavivirus RNA replication.

Authors:  Sai Wang; Kitti Wing Ki Chan; Min Jie Alvin Tan; Charlotte Flory; Dahai Luo; Julian Lescar; Jade K Forwood; Subhash G Vasudevan
Journal:  RNA       Date:  2021-11-10       Impact factor: 4.942

Review 7.  Virus-like Particles: Measures and Biological Functions.

Authors:  Tara Bhat; Amy Cao; John Yin
Journal:  Viruses       Date:  2022-02-14       Impact factor: 5.048

8.  Transcriptional and Translational Dynamics of Zika and Dengue Virus Infection.

Authors:  Kamini Singh; Maria Guadalupe Martinez; Jianan Lin; James Gregory; Trang Uyen Nguyen; Rawan Abdelaal; Kristy Kang; Kristen Brennand; Arnold Grünweller; Zhengqing Ouyang; Hemali Phatnani; Margaret Kielian; Hans-Guido Wendel
Journal:  Viruses       Date:  2022-06-28       Impact factor: 5.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.